Cargando…

Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia

Recent studies have underscored the importance of gamma-delta (γδ) T cells in mediating potent MHC-unrestricted cytotoxicity in numerous malignancies. Here, we analyzed Vδ1 and Vδ2 γδ T cell subsets in newly diagnosed chronic myeloid leukemia (CML) patients (n = 40) who had initiated tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knight, Andrea, Piskacek, Martin, Jurajda, Michal, Prochazkova, Jirina, Racil, Zdenek, Zackova, Daniela, Mayer, Jiri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110709/ https://www.ncbi.nlm.nih.gov/pubmed/36376516 http://dx.doi.org/10.1007/s00262-022-03312-3

Ejemplares similares

Expansion of vdelta1 T lymphocytes reactive to c. albicans IN HIV-1 infected patients: effect of influenza virus vaccine
por: Zocchi, Maria Raffaella, et al.
Publicado: (2010)

The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients
por: Belohlavkova, Petra, et al.
Publicado: (2018)

Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy
por: Pavlík, Tomáš, et al.
Publicado: (2011)

Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin
Publicado: (1996)

Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing
por: Hudecek, Robert, et al.
Publicado: (2021)

Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspects
por: Culen, Martin, et al.
Publicado: (2016)

Alkaline Phosphatase in Stem Cells
por: Štefková, Kateřina, et al.
Publicado: (2015)

A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel
por: Šestáková, Šárka, et al.
Publicado: (2022)

Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin
por: Kuželová, Kateřina, et al.
Publicado: (2018)

Population modeling of bosutinib exposure‐response in patients with newly diagnosed chronic phase chronic myeloid leukemia
por: Garrett, May, et al.
Publicado: (2023)

Mathematical and numerical methods for the nonlinear hyperbolic propagation problem delta$^{2}$GAMMA/delta.t$^{2}$ = (delta/delta.z)((delta.GAMMA(delta.t)(delta.GAMMA/delta.z)): a preliminary treatment of collective space
por: Funk, U N, et al.
Publicado: (1982)

C-Reactive Protein Promotes the Expansion of Myeloid Derived Cells With Suppressor Functions
por: Jimenez, Rachel V., et al.
Publicado: (2019)

Feasibility of fractionated gamma knife radiosurgery in the management of newly diagnosed Glioblastoma
por: Gallitto, Matthew, et al.
Publicado: (2022)

The presence of an endogenous murine leukemia virus sequence correlates with the peripheral expansion of gamma delta T cells bearing the BALB invariant delta (BID) T cell receptor delta
Publicado: (1993)

Optimization of methods for peripheral blood mononuclear cells isolation and expansion of human gamma delta T cells
por: Khan, Mohd Wajid Ali, et al.
Publicado: (2021)

The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Newly Diagnosed Acute Myeloid Leukaemia Patients
por: Dou, Liurui, et al.
Publicado: (2022)

The prognostic impact of lymphocyte subsets in newly diagnosed acute myeloid leukemia
por: Park, Yumi, et al.
Publicado: (2018)

Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid Leukemia
por: Wasylyshyn, Anastasia I., et al.
Publicado: (2021)

Digital PCR can provide improved BCR-ABL1 detection in chronic myeloid leukemia patients in deep molecular response and sensitivity of standard quantitative methods using EAC assays
por: Smitalova, Dagmar, et al.
Publicado: (2021)

Current experimental status of $ \Delta \Gamma$ and $ \Delta m$
por: Schiller, Manuel Tobias
Publicado: (2018)

A measurement of $\Delta \Gamma_{s}$
por: Aaij, Roel, et al.
Publicado: (2023)

Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
por: Fenaux, Pierre, et al.
Publicado: (2023)

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
por: Togasaki, E, et al.
Publicado: (2017)

The UK SPIRIT 1 trial in newly-diagnosed chronic myeloid leukaemia (CML)
por: Gallipoli, Paolo, et al.
Publicado: (2022)

Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults
por: Yoo, Kwai Han, et al.
Publicado: (2020)

The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
por: Liu, Chia‐Jen, et al.
Publicado: (2020)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
por: Niparuck, Pimjai, et al.
Publicado: (2021)

CPX-351 induces remission in newly diagnosed pediatric secondary myeloid malignancies
por: Hu, Yixin, et al.
Publicado: (2022)

PB1842: EARLY DEATH IN NEWLY DIAGNOSED ADULT ACUTE MYELOID LEUKEMIA
por: Siala, N., et al.
Publicado: (2022)

Measurements of $\Delta m_{d,s}$ and $\Delta\Gamma_d$ at LHCb
por: Vecchi, Stefania
Publicado: (2017)

Measurements of $\Delta m_{d,s}$ and $\Delta \Gamma_d$ at LHCb
por: Vecchi, Stefania
Publicado: (2016)

LHC Perspectives for b lifetimes, $\Delta m, \Delta\Gamma$
por: Robbe, Patrick
Publicado: (2008)

Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma.
por: Färkkilä, M., et al.
Publicado: (1994)

Studies $\Delta\Gamma_{s}/\Gamma_{s}$ and $sin 2\beta$ in ALEPH
por: Spagnolo, P
Publicado: (2000)

Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients
por: Lim, Ming Y, et al.
Publicado: (2014)

Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia
por: Getz, Kelly D., et al.
Publicado: (2018)

Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
por: Garciaz, Sylvain, et al.
Publicado: (2022)

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
por: Cherry, Evan M., et al.
Publicado: (2021)

Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia
por: Liu, Qingguo, et al.
Publicado: (2020)

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia
por: Fleischmann, Maximilian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rri5q7lo6nkv8bkhvjrknco00n